Synergistic killing of human leukemia cells by antioxidants and trichostatin A

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 6, 2004, Pages 537-545

  Kang, Jiuhong ^a   Chen, Jie ^b   Zhang, Dawei ^a   Da, Wanming ^c   Ou, Yingxian ^b  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Ascorbic acid; Cytotoxicity; Histone acetylation; N acetyl cysteine; Reactive oxygen species; Trichostatin A

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; HISTONE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; TRICHOSTATIN A;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DAMAGE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ACETYLATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HISTONES; HL-60 CELLS; HUMANS; HYDROXAMIC ACIDS; L-LACTATE DEHYDROGENASE; LEUKEMIA; REACTIVE OXYGEN SPECIES;

EID: 11144349681     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0845-7     Document Type: Article

References (43)

1. Deshpande SS, Irani K (2002) Oxidant signalling in carcinogenesis: a commentary. Hum Exp Toxicol 21:63-64
2. Park CH, Amare M, Savin MA, Hoogstraten B (1980) Growth suppression of human leukemic cells in vitro by L-ascorbic acid. Cancer Res 40:1062-1065
3. Park CH, Kimler BF (1991) Growth modulation of human leukemic, preleukemic, and myeloma progenitor cells by L-ascorbic acid. Am J Clin Nutr 54:1241S-1246S
4. Kang J, Shi Y, Zheng R (1999) Effects of ascorbic acid on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 20:1019-1024
5. Kang J, Shi Y, Zheng R (2000) Effects of ascorbic acid and DL-alpha-tocopherol on human hepatoma cell proliferation and redifferentiation. Acta Pharmacol Sin 21:348-352
6. Riordan NH, Riordan HD, Meng YL, Jackson JA (1995) Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent. Med Hypotheses 44:207-213
7. Riordan NH, Riordan HD, Casciari JP (2000) Clinical and experimental experiences with intravenous vitamin C. J Orthomol Med 5:201-213
8. Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson WA (1994) Modification of the effect of tamoxifen, cisplatin, DTIC and interferon-2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 22:233-245
9. Prasad KN, Kumar A, Kochupillai V, Cole WC (1999) High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18:13-25
10. Cameron E, Pauling L (1976) Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 73:3685-3689
11. Drisko JA, Chapman J, Hunter VJ (2003) The use of antioxidant therapies during chemotherapy. Gynecol Oncol 88:434-439
12. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy: impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37:1-18
13. McCall MR, Frei B (1999) Can antioxidant vitamins materially reduce oxidative damage in humans? Free Radic Biol Med 26:1034-1053
14. Prasad KN, Cole W, Hoveland P (1998) Cancer prevention studies: past, present, and future. Nutrition 14:197-210
15. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ (1997) Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21 WAF1/CIP1 via C/EBPβ Nat Med 3:1233-1241
16. Weijl NI, Cleton FJ, Osanto S (1997) Free radicals and antioxidants in chemotherapy induced toxicity. Cancer Treat Rev 23:209-240
17. Labriola D, Livingston R (1999) Possible interactions between dietary antioxidants and chemotherapy. Oncology 13:1003-1012
18. Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH, Sivashinskiy MS, Van Dyke TA (2000) Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21:909-914
19. Archer SY, Hodin RA (1999) Histones acetylation and cancer. Curr Opin Gene Dev 9:171-174
20. Klochendler-Yeivin A, Yaniv M (2001) Chromatin modifiers and tumor suppression. Biochim Biophys Acta 1551:M1-M10
21. Lehrmann H, Pritchard LL, Harel-Bellan A (2002) Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv Cancer Res 86:41-65
22. Fry CJ, Peterson CL (2002) Unlocking the gates to gene expression. Science 295:1847-1848
23. Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349-352
24. Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG (2001) Aberrant pattern of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10:687-692
25. Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210-1216
26. Henderson C, Brancolini C (2003) Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype. Drug Resist Updat 6:247-256
27. Yamashita Y, Shimada M, Harimoto N, Rikimaru T, Shirabe K, Tanaka S, Sugimachi K (2003) Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells. Int J Cancer 103:572-576
28. Donadelli M, Costanzo C, Faggioli L, Scupoli MT, Moore PS, Bassi C, Scarpa A, Palmieri M (2003) Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells. Mol Carcinog 38:59-69
29. Rosato RR, Grant S (2003) Histone deacetylase inhibitors in cancer therapy. Cancer Biol Ther 2:30-37
30. Marks PA, Richon VM, Breslow R, Rifkind RA (2001) Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 13:477-483
31. Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F (2003) Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63:7291-7300
32. Wroblewski F, La Due J (1995) Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90:210-213
33. LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 29,79-dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227-231
34. Cousens LS, Gallwitz D, Alberts BM (1979) Different accessibilities in chromatin to histone acetylase. J Biol Chem 254:1716-1723
35. Del Raso N (1992) In vitro methods for assessing chemical or drug toxicity and metabolism in primary hepatocytes. In: Watson RR (ed) In vitro methods of toxicology. CRC, Boca Raton, pp 176-201
36. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S (1979) Failure of high dose vitamin C (ascorbic acid) to benefit patients with advanced cancer: a controlled trial. N Engl J Med 301:687-690
37. Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM (1985) High dose vitamin C versus placebo in the treatment of patients with advanced cancer who had had no prior chemotherapy: a randomized double-blind comparison. N Engl J Med 312:137-141
38. Zafarullah M, Li WQ, Sylvester J, Ahmad M (2003) Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci 60:6-20
39. He L, Tolentino T, Grayson P, Zhong S, Warrell RP, Rifkind RA, Marks PA, Richon VM, Pandolfi PP (2001) Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia. J Clin Invest 108:1321-1330
40. Lee YS, Jin DQ, Park SH, Han SY, Kim HS, Jeong TC, Huh K, Kim JA (2002) 2,3,7,8-Tetrachlorobenzo-p-dioxin inhibits proliferation of SK-N-SH human neuronal cells through decreased production of reactive oxygen species. Free Radic Res 36:1283-1289
41. Gorlach A, Kietzmann T, Hess J (2002) Redox signaling through NADPH oxidases: involvement in vascular proliferation and coagulation. Ann N Y Acad Sci 973:505-507
42. Burdon RH (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18:775-794
43. 2+. Redox Rep 9:37-48